GOLDMAN SACHS GROUP INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$3,768,745
-68.5%
402,214
-17.6%
0.00%
-50.0%
Q2 2023$11,968,236
+29.9%
487,902
+23.3%
0.00%0.0%
Q1 2023$9,210,429
-41.0%
395,807
-35.9%
0.00%
-33.3%
Q4 2022$15,620,244
+17.6%
617,157
-10.4%
0.00%0.0%
Q3 2022$13,280,000
+11.2%
688,782
+46.8%
0.00%0.0%
Q2 2022$11,947,000
-24.8%
469,080
-24.1%
0.00%0.0%
Q1 2022$15,889,000
-31.9%
617,750
+10.8%
0.00%
-40.0%
Q4 2021$23,338,000
-13.0%
557,382
-9.5%
0.01%
-16.7%
Q3 2021$26,812,000
+9.2%
616,095
+18.6%
0.01%0.0%
Q2 2021$24,559,000
-52.1%
519,446
-48.0%
0.01%
-53.8%
Q1 2021$51,226,000
+246.4%
999,142
+80.9%
0.01%
+225.0%
Q4 2020$14,789,000
+6.3%
552,233
+36.2%
0.00%0.0%
Q3 2020$13,917,000
+322.4%
405,371
+404.0%
0.00%
+300.0%
Q2 2020$3,295,000
+78.8%
80,437
+49.6%
0.00%0.0%
Q1 2020$1,843,000
+984.1%
53,765
+297.3%
0.00%
Q4 2019$170,00013,5330.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders